IsoPlexis reports the publication of a study in which researchers used IsoPlexis’ single-cell functional proteomics platform to identify factors that may predict sustained disease after COVID-19 infection, also known as Post-Acute Sequelae of COVID-19 (PASC) or Long COVID.
In the study, researchers correlated patient symptoms with in-depth profiling of blood cells and plasma components throughout COVID-19 infection to identify factors associated with the development of PASC.
Using IsoPlexis’ single-cell functional proteomics platform, the researchers were able to identify correlations between the enhanced presence of certain polyfunctional immune cell types and the presentation of inflammation associated with PASC.